Bank Julius Baer & Co’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bank Julius Baer & Co’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-617	Closed	-$102K	–	885
2021 Q2	$102K	Sell	617 -15,143	-96%	-$2.53M	﹤0.01%	636
2021 Q1	$2.42M	Buy	15,760 +2,216	+16%	+$301K	0.02%	254
2020 Q4	$1.7M	Buy	13,544 +2,085	+18%	+$233K	0.01%	278
2020 Q3	$1.16M	Sell	11,459 -356	-3%	-$36.3K	0.01%	280
2020 Q2	$1.15M	Sell	11,815 -2,358	-17%	-$219K	0.01%	254
2020 Q1	$1.18M	Buy	+14,173	New	+$1.38M	0.03%	205

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Bank Julius Baer & Co's PRAH Position: Q3 2021 in Review

Bank Julius Baer & Co sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 617 shares — an estimated $102K sold.

Bank Julius Baer & Co first reported a position in PRAH in Q1 2020 and held it in 6 quarters. The position peaked at $2.42M in Q1 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Bank Julius Baer & Co reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Bank Julius Baer & Co sold 617 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $102K.
Bank Julius Baer & Co first reported a position in PRA Health Sciences, Inc. in Q1 2020 and held it in 6 quarters.
Bank Julius Baer & Co's PRA Health Sciences, Inc. position peaked at $2.42M in Q1 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Bank Julius Baer & Co's 13F filing for Q3 2021, filed 12 Nov 2021.